Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer
Clinical trial NCT06064500 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT06064500
- Sponsor
- Amgen
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.